- Home
- Publications
- Publication Search
- Publication Details
Title
Updates in Anthracycline-Mediated Cardiotoxicity
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-12
DOI
10.3389/fphar.2018.01262
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of prophylactic betablocker or ACE inhibitor on cardiac dysfunction & heart failure during anthracycline chemotherapy ± trastuzumab
- (2018) Dorothy M. Gujral et al. BREAST
- New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations
- (2018) Elisabetta Bigagli et al. INVESTIGATIONAL NEW DRUGS
- Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity
- (2018) Xi Yang et al. JOURNAL OF APPLIED TOXICOLOGY
- Clarifying the Proper Definitions for Type 2 Myocardial Infarction
- (2018) Kristian Thygesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cargo-Free Nanomedicine with pH Sensitivity for Codelivery of DOX Conjugated Prodrug with SN38 To Synergistically Eradicate Breast Cancer Stem Cells
- (2018) Na Sun et al. MOLECULAR PHARMACEUTICS
- Mitochondria-based aircraft carrier enhances in vivo imaging of carbon quantum dots and delivery of anticancer drug
- (2018) Wen-Qing Li et al. Nanoscale
- Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone
- (2018) Roberto Marques Damiani et al. TOXICOLOGY IN VITRO
- Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes
- (2018) David A Knowles et al. eLife
- Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
- (2018) Gantumur Battogtokh et al. Frontiers in Pharmacology
- Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy
- (2017) Daniela Cardinale et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
- (2017) Peter A Henriksen HEART
- Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients
- (2017) Clarissa Ruggeri et al. HEART FAILURE REVIEWS
- Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations
- (2017) Ruijuan Luo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
- (2017) Nickhill Bhakta et al. LANCET
- Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
- (2017) Donato Cappetta et al. Oxidative Medicine and Cellular Longevity
- Phytotherapy and Nutritional Supplements on Breast Cancer
- (2017) C. M. Lopes et al. Biomed Research International
- Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells
- (2017) Runmin Guo et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression
- (2017) Shashi Kumar Gupta et al. CIRCULATION RESEARCH
- An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice
- (2017) Megan D. Montgomery et al. PLoS One
- Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study
- (2017) Anita Boyd et al. PLoS One
- Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
- (2017) Liqun Zhao et al. Scientific Reports
- miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway
- (2016) Zhongwei Yin et al. Aging-US
- Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
- (2016) Roberto Marques Damiani et al. ARCHIVES OF TOXICOLOGY
- New signal transduction paradigms in anthracycline-induced cardiotoxicity
- (2016) Alessandra Ghigo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
- (2016) Giuseppe Curigliano et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity
- (2016) Hong Zhan et al. CARDIOVASCULAR RESEARCH
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN JOURNAL OF HEART FAILURE
- SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy
- (2016) Donato Cappetta et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity
- (2016) Nicola Maurea et al. Journal of Cardiovascular Medicine
- H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance
- (2016) Konstantin Chegaev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of NOX2 in mediating doxorubicin-induced senescence in human endothelial progenitor cells
- (2016) Elena De Falco et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
- (2016) Paul W Burridge et al. NATURE MEDICINE
- Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications
- (2016) Xin Gen Lei et al. PHYSIOLOGICAL REVIEWS
- VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
- (2016) Markus Räsänen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity
- (2016) Marcela Pizarro et al. TOXICOLOGY
- Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity
- (2016) YA-DI WANG et al. Oncology Letters
- The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity
- (2016) Edoardo Lazzarini et al. Scientific Reports
- Mitochondrial Targeting of Doxorubicin Eliminates Nuclear Effects Associated with Cardiotoxicity
- (2015) Sae Rin Jean et al. ACS Chemical Biology
- Mending a broken heart: the role of mitophagy in cardioprotection
- (2015) Alexandra G. Moyzis et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy
- (2015) Anne Hamacher-Brady et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Molecular Mechanisms of Mitochondrial Autophagy/Mitophagy in the Heart
- (2015) T. Saito et al. CIRCULATION RESEARCH
- Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity
- (2015) Eric S. Christenson et al. CLINICAL BIOCHEMISTRY
- The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
- (2015) M. Volpe et al. CLINICAL SCIENCE
- Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors
- (2015) Konrad Urbanek et al. CURRENT DRUG TARGETS
- Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment
- (2015) Asuka Yasueda et al. INTEGRATIVE CANCER THERAPIES
- SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells
- (2015) Antonella De Angelis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiotoxicity of anticancer treatments
- (2015) Michael S. Ewer et al. Nature Reviews Cardiology
- Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
- (2015) Paweorn Angsutararux et al. Oxidative Medicine and Cellular Longevity
- Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes
- (2015) Patrizia Fabbi et al. PLoS One
- The Role of Reactive Oxygen Species in Mesenchymal Stem Cell Adipogenic and Osteogenic Differentiation: A Review
- (2015) Fatemeh Atashi et al. STEM CELLS AND DEVELOPMENT
- An overview of doxorubicin formulations in cancer therapy
- (2015) Sangeeta Rivankar Journal of Cancer Research and Therapeutics
- Cardiovascular disease after cancer therapy
- (2014) Berthe M.P. Aleman et al. EJC SUPPLEMENTS
- Overexpression of Vascular Endothelial Growth Factor 165 (VEGF165) Protects Cardiomyocytes Against Doxorubicin-Induced Apoptosis
- (2014) Tingting Chen et al. JOURNAL OF CHEMOTHERAPY
- Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
- (2014) Yoshihiko Ichikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin
- (2014) Jenelle Govender et al. JOURNAL OF PINEAL RESEARCH
- Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction
- (2014) Siying Li et al. Oxidative Medicine and Cellular Longevity
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling
- (2014) Rimpy Dhingra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Delivery of Doxorubicin to Mitochondria
- (2013) Graham R. Chamberlain et al. ACS Chemical Biology
- Doxorubicin induces senescence and impairs function of human cardiac progenitor cells
- (2013) Elena Piegari et al. BASIC RESEARCH IN CARDIOLOGY
- A comparison of replicative senescence and doxorubicin-induced premature senescence of vascular smooth muscle cells isolated from human aorta
- (2013) Anna Bielak-Zmijewska et al. BIOGERONTOLOGY
- Doxorubicin-antioxidant co-drugs
- (2013) Konstantin Chegaev et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic Potential
- (2013) Steven M. Jay et al. CIRCULATION
- Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity
- (2013) P Vejpongsa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
- (2013) Filipa S. Carvalho et al. MEDICINAL RESEARCH REVIEWS
- Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells
- (2013) RUN-MIN GUO et al. Molecular Medicine Reports
- Comparative Cardiac Toxicity of Anthracyclines In Vitro and In Vivo in the Mouse
- (2013) Stefano Toldo et al. PLoS One
- Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy Inhibitor
- (2013) Mayel Gharanei et al. PLoS One
- Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts
- (2013) Kendra K.S. Nordgren et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cells
- (2013) Maira Souza Oliveira et al. TOXICOLOGY LETTERS
- Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity
- (2012) Balindiwe J.N. Sishi et al. BIOCHEMICAL PHARMACOLOGY
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
- (2012) Steven E. Lipshultz et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome
- (2011) Kristin A. D. Sauter et al. CANCER BIOLOGY & THERAPY
- The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats
- (2011) V. Ashutosh Rao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications
- (2011) Aspasia Soultati et al. CANCER TREATMENT REVIEWS
- The aging effect of chemotherapy on cultured human mesenchymal stem cells
- (2011) Stefano Buttiglieri et al. EXPERIMENTAL HEMATOLOGY
- Mechanisms and management of doxorubicin cardiotoxicity
- (2011) Y. Shi et al. HERZ
- CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes
- (2011) Can M. Sag et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice
- (2010) Kaushik Vedam et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Juvenile Exposure to Anthracyclines Impairs Cardiac Progenitor Cell Function and Vascularization Resulting in Greater Susceptibility to Stress-Induced Myocardial Injury in Adult Mice
- (2010) Chengqun Huang et al. CIRCULATION
- Androgen Receptor Counteracts Doxorubicin-Induced Cardiotoxicity in Male Mice
- (2010) Yasumasa Ikeda et al. MOLECULAR ENDOCRINOLOGY
- p38 MAPK and JNK Antagonistically Control Senescence and Cytoplasmic p16INK4A Expression in Doxorubicin-Treated Endothelial Progenitor Cells
- (2010) Paolo Spallarossa et al. PLoS One
- Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy
- (2010) Rui A. Carvalho et al. TOXICOLOGY
- Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
- (2009) Partha Mukhopadhyay et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function
- (2009) Antonella De Angelis et al. CIRCULATION
- Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy
- (2009) Mark J. Ranek et al. CURRENT HYPERTENSION REPORTS
- Doxorubicin increases the susceptibility of brain mitochondria to Ca2+-induced permeability transition and oxidative damage
- (2008) Susana Cardoso et al. FREE RADICAL BIOLOGY AND MEDICINE
- Interaction of anthracyclines with iron responsive element mRNAs
- (2008) Joshua C. Canzoneri et al. NUCLEIC ACIDS RESEARCH
- Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy
- (2007) Masayasu Esaki et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started